- Home
- KRYS vs NGD Comparison
KRYS vs NGD Comparison
Compare KRYS & NGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRYS
- NGD
- Stock Information
- Founded
- KRYS 2015
- NGD N/A
- Country
- KRYS United States
- NGD Canada
- Employees
- KRYS N/A
- NGD N/A
- Industry
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- NGD
- Sector
- KRYS Health Care
- NGD
- Exchange
- KRYS Nasdaq
- NGD Nasdaq
- Market Cap
- KRYS 4.7B
- NGD 3.9B
- IPO Year
- KRYS 2017
- NGD 2004
- Fundamental
- Price
- KRYS $183.36
- NGD $7.35
- Analyst Decision
- KRYS Strong Buy
- NGD Buy
- Analyst Count
- KRYS 9
- NGD 2
- Target Price
- KRYS $203.22
- NGD $5.50
- AVG Volume (30 Days)
- KRYS 384.0K
- NGD 18.4M
- Earning Date
- KRYS 11-03-2025
- NGD 10-28-2025
- Dividend Yield
- KRYS N/A
- NGD N/A
- EPS Growth
- KRYS 36.22
- NGD N/A
- EPS
- KRYS 4.91
- NGD 0.18
- Revenue
- KRYS $359,205,000.00
- NGD $1,031,700,000.00
- Revenue This Year
- KRYS $34.33
- NGD $51.54
- Revenue Next Year
- KRYS $47.84
- NGD $47.75
- P/E Ratio
- KRYS $37.38
- NGD $40.11
- Revenue Growth
- KRYS 116.08
- NGD 27.25
- 52 Week Low
- KRYS $122.80
- NGD $2.43
- 52 Week High
- KRYS $207.84
- NGD $7.59
- Technical
- Relative Strength Index (RSI)
- KRYS 76.57
- NGD 78.96
- Support Level
- KRYS $158.08
- NGD $7.02
- Resistance Level
- KRYS $183.36
- NGD $7.21
- Average True Range (ATR)
- KRYS 6.02
- NGD 0.27
- MACD
- KRYS 2.37
- NGD 0.01
- Stochastic Oscillator
- KRYS 99.31
- NGD 81.01
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
About NGD New Gold Inc.
New Gold Inc participates in the development and operation of intermediate mining properties. The company has a portfolio of two primary assets which are also its operating segments: the Rainy River Mine and the New Afton Mine in Canada. The company also owns the Cerro San Pedro Mine in Mexico. The company derives revenue from the sale of gold, copper, and silver.